Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-28

FDA Approved: RIVELSA — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Rivelsa, Teva's oral contraceptive, under an original NDA for pregnancy prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIVELSA (LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for RIVELSA (LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL)